UBS Maintains Neutral on Medtronic, Lowers Price Target to $85

Benzinga Newsdesk www.benzinga.com Negative 69.4%

Neg 69.4% Neu 0% Pos 0%

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $90 to $85.

Comments

No comments yet. Be the first!